OBJECTIVE Cardioembolic stroke accounts for nearly 30% of ischemic strokes. Prompt diagnosis of the underlying mechanism may improve secondary prevention strategies. This article reviews recent randomized trials, observational studies, case reports, and guidelines on the diagnosis and treatment of ...
We review the recent clinical literature about the natural history, diagnosis, and management of cardioembolic stroke. Long-term anticoagulati... None - 《Archives of Neurology》 被引量: 415发表: 1986年 Atrial Fibrillation-a Review of Course and Prognosis Atrial fibrillation: natural history, ...
Cardioembolic stroke related to nonvalvular atrial fibrillation is associated with a high recurrence rate and high mortality and morbidity. In this populat... KH Jung,유경호,김영대,... - 대한뇌졸중학회지 被引量: 0发表: 2015年 Antithrombotic management of stroke patients...
Cardioembolic stroke (CES) due to atrial fibrillation (AF) is associated with high stroke mortality. Oral anticoagulation (OAC) reduces stroke mortality, however, the impact of OAC-administration during hospital stay post ischemic stroke on mortality is
Atrial fibrillation (AF) is the most common heart rhythm problem and a leading cause of morbidity and mortality. Serious complications associated with this disorder include cardioembolic stroke, heart failure, and death. The worldwide prevalence of AF is rapidly increasing owing to aging of the popu...
Antiplatelet therapy is an integral component of effective secondary prevention after non-cardioembolic ischemic stroke. Numerous clinical trials have test... J Biller - 《Journal of the Neurological Sciences》 被引量: 44发表: 2009年 Role of antiplatelet therapy in cardiovascular disease II: Ischemic ...
38. De Gregorio C, Grimaldi P, Lentini C, Left ventricular thrombus formation and cardioembolic complications in patients with takotsubo-like syndrome: A systematic review: Int J Cardiol, 2008; 131; 18-24 39. Akashi YJ, Tejima T, Sakurada H, Left ventricular rupture associated with takotsubo ...
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention Nat Rev Cardiol, 15 (2018), pp. 480-496 CrossrefView in ScopusGoogle Scholar 27 P. Vranckx, M. Valgimigli, P. Jüni, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 mo...
Patients with chronic HF with permanent/persistent/paroxysmal AF and an additional risk factor for cardioembolic stroke should receive chronic anticoagulant therapy∗ I A 210, 211, 212, 213, 214, 215, 216 The selection of an anticoagulant agent should be individualized I C N/A Chronic anticoagul...
of incident and recurrent stroke, reduced need for surgical intervention, image-based triage decisions to decide the best course of acute ischemic stroke management and possible potential of safer, longer-acting drugs in acute thrombolysis, and prevention of recurrent cardioembolic stroke. Potential ...